From its headquarters in Crumlin, Northern Ireland, Randox has grown into an international success story, at the frontline of improving healthcare in conditions such as stroke, dementia, diabetes, heart disease, sexually transmitted infections (STIs) and respiratory infections through earlier and more accurate diagnosis.
Every year some 350 million people – 5% of the world’s population – are diagnosed using Randox products, and the company supplies 10% of the world’s cholesterol tests, and 8% of all clinical chemistry tests undertaken globally.
Randox is striding forward: driven by innovation and a commitment to saving lives, Randox has ambitious plans to develop the Randox Science Park in Antrim, a centre for excellence in clinical research and development, engineering and transformative health.
www.randox.com
